Research News
Explore our curated selection of the latest breakthroughs in lung cancer research.
January 12, 2021
Lung cancer screenings down due to COVID. Drop in lung cancer screenings due to canceled or postponed services has led to worse patient outcomes.
Diagnostic Imaging
January 8, 2021
Tagrisso as adjuvant therapy for non-small cell lung cancer approved by the FDA for patients who have had tumor resection.
CURE®
January 8, 2021
Amgen has filed its trailblazer KRAS inhibiting drug treatment with the FDA for a group of lung cancer patients with an aggressive form of the disease.
PharmaPhorum
Learn more about:
LCFA prioritizes providing reliable information about new diagnostics, treatments, and prevention strategies, including exciting FDA-approved personalized therapies based on individual tumor biomarkers.